Paul Govern Archive — Page 21 of 54
-
September 9, 2021
Froehler elected a second time to surgery society board
For a second consecutive year, Vanderbilt's Michael Froehler, MD, PhD, has been elected a member of the board of directors of the Society of NeuroInterventional Surgery (SNIS). -
September 2, 2021
Using billing codes to count cancers
The billing codes in electronic health records are useful for counting skin cancers over time — an important metric for cancer risk assessment and prevention. -
September 2, 2021
Study shows gene-drug interactions are common
When a drug or combination of drugs causes different responses in different people, genetic variation is often at play. Pharmacogenomics, through discovery of genetic risk and use of clinical genotyping, aims to reduce trial-and-error approaches to drug prescribing. -
August 26, 2021
One Hundred Oaks EVS staff at 500 injury-free days and counting
At Vanderbilt Health One Hundred Oaks, among the 40 full-time Aramark Corp. employees who work under contract to provide environmental services — EVS, an industry term for health care cleaning services — there has not been an injury requiring medical attention in more than 500 days. -
August 12, 2021
Wanjalla honored by Doris Duke Foundation
Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award. -
August 12, 2021
Certain drug exposures correlate with reduced COVID severity: study
Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.